NuScale Power’s stock has been hit hard, with a steep 81.9% decline over the past year, while its broader valuation checks lean expensive rather than like a clear bargain, even though the share price already reflects a lot of pessimism after recent setbacks. Over the past 12 months, NuScale Power has fallen 81.9%, which puts the stock firmly in recovery-story territory for any investor considering a fresh valuation case. On the one hand, NuScale’s small modular reactor rollout is positioned...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Oklo, X-Energy, NuScale Power, Nano Nuclear Energy and Uranium Energy lost between 8% and 9% on Thursday due to a combination of valuation concerns, profit-taking, and AI-related worries.
Investors debate whether heavy spending on AI infrastructure will deliver profits fast enough to justify the rising costs.
Nuclear stocks looked unstoppable just weeks ago, but a brutal month-long selloff has split the sector into two very different stories, and knowing which side you are on could determine whether you hold, buy the dip, or walk away entirely.
NuScale Power, The Metals Company, and SunPower shares declined to annual lows amid largely negative sentiment and a broader market selloff.
NuScale Power (NYSE:SMR) is facing a legal challenge over claims it misrepresented the project experience of commercialization partner ENTRA1 in investor communications. The dispute raises questions about disclosure practices and potential legal and reputational consequences for future NuScale projects. Separately, NuScale awarded Paragon an engineering contract to design the highly integrated protection system for its certified small modular reactor modules. NuScale is currently the only...
Today, June 5, 2026, investors are weighing fresh policy tailwinds and new SMR applications against NuScale’s shifting risk profile.
In the past quarter, NuScale Power reported Q1 2026 sales of US$565,000 versus US$13.38 million a year earlier, with net loss widening to US$44.02 million and basic loss per share from continuing operations rising to US$0.14. At the same time, NuScale is pressing ahead with large-scale SMR commercialization efforts and facing heightened legal scrutiny over alleged misleading partnership disclosures, creating a complex mix of operational progress and risk for investors to weigh. Next, we’ll...
NuScale Power’s consolidated fair value estimate has been trimmed from US$20.42 to US$16.50, a reduction of roughly 19% that puts a smaller price target at the center of the latest reset in expectations. Recent research points to execution risk, capital needs, active share sales, and long commercialization timelines as key reasons many firms are lowering fair value assumptions, even as some analysts remain constructive. As you read on, you will see how these shifting targets and the debate...
FLR's Q1 2026 EPS and revenues miss estimates as legal and project charges hit results, sending shares down 15.2% on Friday.
A major study of 6,500 beaten-down stocks reveals that history may be more forgiving than you'd expect.
SMR shares fall 5% after Q1 earnings and revenues miss expectations as RoPower-related activity declines and operating expenses climb.
Fluor reports adjusted earnings per share of 14 cents from sales of almost $3.7 billion. Wall Street expected earnings per share of 52 cents from sales of $9.2 billion.
Nuclear stocks Vistra, NuScale Power and Energy Fuels prepare to report earnings on Thursday, while Oklo awaits. Oklo stock jumped on news Wednesday that also lifted most of its peers, but not S&P 500 nuclear stock Vistra.
Fluor was an early investor in NuScale Power in 2011.